West Pharmaceutical Services Finance Lease, Right-of-Use Asset, after Accumulated Amortization decreased by 2.0% to $34.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $32.00M to $34.00M.
A stable or increasing value suggests continued investment in leased capital assets, while a decrease may indicate aging assets or reduced investment.
This represents the net book value of assets acquired via finance leases after accounting for accumulated amortization....
Comparable to property, plant, and equipment (PP&E) metrics for companies that favor leasing over purchasing.
other_finance_lease_right_of_use_asset| Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $31.00M | $31.90M | $29.70M | $32.00M | $35.00M | $35.20M | $34.70M | $34.00M |
| QoQ Change | — | +2.9% | -6.9% | +7.7% | +9.4% | +0.6% | -1.4% | -2.0% |
| YoY Change | — | — | — | — | +12.9% | +10.3% | +16.8% | +6.3% |